WHO backs AstraZeneca COVID vaccine amid blood clot concerns - News Summed Up

WHO backs AstraZeneca COVID vaccine amid blood clot concerns


The UN World Health Organization (WHO) said on Friday that it was aware of blood clot concerns linked to “a specific batch” of AstraZeneca-Oxford COVID-19 vaccine, but maintained that to date, no-one has died from any coronavirus vaccine. The development comes after several European countries suspended the rollout of the jab as a precaution. “The panel had taken the position that the jab should continue to be administered, while an investigation of cases of these thrombo-embolic events is ongoing”, Dr Harris continued. Hundreds of vaccine candidatesAccording to the WHO COVID-19 vaccine tracker, there are 81 vaccines in clinical development and more than 180 in the pre-clinical development phase. To date, WHO has approved two vaccines for emergency use against COVID-19: the Pfizer/BioNTech vaccine - approved on 31 December 2020 – and two versions of the AstraZeneca/Oxford vaccine, on 15 February 2021.


Source: The Nation March 13, 2021 04:41 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */